La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Radical libre And NotTakefumi Suzuki

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000624 XINGSHUN XU [États-Unis] ; Chu C. Chua [États-Unis] ; JIMING KONG [Canada] ; Richard M. Kostrzewa [États-Unis] ; Udayasankar Kumaraguru [États-Unis] ; Ronald C. Hamdy [États-Unis] ; Balvin H. L. Chua [États-Unis]Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells
000A57 Andrzej Friedman [Pologne] ; Jolanta Galazka-Friedman [Pologne]The current state of free radicals in Parkinson's disease: Nigral iron as a trigger of oxidative stress
000D60 C.-T. Lai [Canada] ; P. H. Yu [Canada]R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells
000D91 C.-T. Lai [Canada] ; P. H. Yu [Canada]Dopamine- and L-β-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells : effects of oxidative stress and antioxidative factors
000E25 G. Trepanier [Canada] ; D. Furling [Canada] ; J. Puymirat [Canada] ; M.-E. Mirault [Canada]Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain
000E73 G. M. Ross [Canada] ; B. E. Mccarry ; R. K. Mishra [Canada]Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene
000F55 J. Poirier [Canada] ; C. ThiffaultAre free radicals involved in the pathogenesis of idiopathic Parkinson's disease ?
000F65 D. B. Calne [Canada]The free radical hypothesis in idiopathic Parkinsonism : evidence against it
000F81 J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; A. K. Chaudhary ; KAILASH PRASADOxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease
001019 J. A. Jesberger ; J. S. RichardsonOxygen free radicals and brain dysfunction
001116 J. D. Grimes ; M. N. Hassan ; J. H. ThakarPrevention of progression of Parkinson's disease with antioxidative therapy

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022